Cationic lipids for intracellular delivery of biologically active molecules
US5264618A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1991 |
| Grant date | Nov 23, 1993 |
| Priority date | — |
| Expiry date | Apr 16, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are cationic lipids capable of facilitating transport of biologically active agents into cells, including the transfection of cells by therapeutic polynucleotides, the delivery of antiviral drugs, and the introduction of immunogenic peptides. The cationic lipids, comprising an ammonium group, have the general structure ##STR1## Also disclosed are adducts of these compounds comprising additional cationic sites that enhance the transfective or transport activity. Structure-activity correlations provide for the selection of preferred compounds to be synthesized for this purpose. Compositions disclosed for use of these cationic lipid include formulations for in vitro transfection and pharmaceutical formulations for parenteral and topical administration of therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.